Leave Your Message

Medical PVC Urine Bag Film Manufacturers & Supplier in India

Leading Innovation in Medical-Grade PVC Film Solutions

Medical PVC Urine Bag Film Industry in India

Market Overview & Growth Potential

The Growing Indian Medical Plastics Market

India's healthcare sector has witnessed exponential growth over the past decade, with the medical plastics industry becoming a cornerstone of this expansion. The demand for medical PVC urine bag films has surged dramatically, driven by India's population of over 1.4 billion people, increasing healthcare accessibility, and rising awareness about hygiene and infection control in medical settings.

The Indian medical disposables market, valued at approximately USD 3.2 billion in 2023, is projected to reach USD 6.8 billion by 2030, growing at a CAGR of 11.2%. Medical PVC films, particularly those used in urine collection bags, represent a significant segment of this growth, accounting for nearly 18% of the medical plastics consumption in the country.

Why Medical PVC Urine Bag Films Matter in Indian Healthcare

Urine collection bags are essential medical devices used across hospitals, nursing homes, home healthcare settings, and during patient transportation. In India, where the geriatric population is expected to reach 300 million by 2050, the demand for urological care products, including urine bags, continues to escalate. Medical-grade PVC films offer the perfect balance of flexibility, durability, transparency, and biocompatibility required for these critical applications.

Indian hospitals and healthcare facilities are increasingly adopting international quality standards such as ISO 13485 and adhering to Medical Device Rules 2017, which mandate the use of certified, non-toxic materials in medical products. This regulatory environment has created substantial opportunities for manufacturers like Jiangsu Dahai Plastics Co., Ltd., who specialize in producing high-quality medical PVC films that meet global compliance standards including EN-71, ASTM-F-963, and RoHS.

Local Manufacturing & Supply Chain Advantages

While India has a robust pharmaceutical manufacturing base, the country still imports significant quantities of specialized medical plastics and films. However, with initiatives like "Make in India" and "Atmanirbhar Bharat," there's a strong push toward localizing medical device manufacturing. International suppliers with proven track records, like DAHAI, are increasingly partnering with Indian distributors and medical device manufacturers to establish reliable supply chains.

The strategic location of manufacturing facilities in regions like Maharashtra, Gujarat, Tamil Nadu, and Karnataka has enabled efficient distribution networks across India. These hubs serve major metropolitan hospitals in Mumbai, Delhi, Bangalore, Chennai, and Hyderabad, while also reaching tier-2 and tier-3 cities where healthcare infrastructure is rapidly developing.

Industry Trends & Future Outlook

Innovation Driving Healthcare Forward

Technological Advancements in Medical PVC Films

The medical PVC film industry is experiencing significant technological evolution. Modern manufacturing processes now incorporate advanced extrusion techniques, multi-layer co-extrusion, and precision thickness control that ensure consistent quality and performance. These innovations are particularly relevant for urine bag applications where film integrity, weld strength, and transparency are critical parameters.

Anti-microbial PVC formulations are gaining traction in the Indian market, addressing the growing concern about hospital-acquired infections (HAIs). These specialized films incorporate silver-ion or copper-based additives that inhibit bacterial growth on the bag surface, providing an additional layer of patient safety.

Sustainability and Environmental Considerations

Environmental consciousness is reshaping the medical plastics industry in India. While PVC has traditionally faced criticism for environmental concerns, modern manufacturing processes have significantly improved its sustainability profile. Manufacturers are now developing phthalate-free, DEHP-free formulations that maintain performance while reducing environmental impact.

The circular economy approach is gaining momentum, with initiatives focused on medical plastic recycling and waste management. Indian healthcare facilities are increasingly seeking suppliers who demonstrate commitment to sustainable practices, creating opportunities for manufacturers with robust environmental management systems.

Regulatory Landscape and Quality Standards

India's Central Drugs Standard Control Organization (CDSCO) has strengthened regulations governing medical devices, including urine collection bags. Manufacturers and suppliers must now demonstrate compliance with stringent biocompatibility testing, cytotoxicity assessments, and quality management system certifications. This regulatory rigor has elevated quality standards across the industry, benefiting patients and healthcare providers alike.

Localized Applications in Indian Healthcare

Meeting Diverse Medical Needs
Hospital & Clinical Settings

Major multi-specialty hospitals across metros like Apollo, Fortis, and Max Healthcare utilize thousands of urine bags daily for post-operative care, ICU patients, and urological procedures. High-quality PVC films ensure patient comfort and clinical reliability.

Home Healthcare

With India's growing home healthcare market projected to reach USD 21 billion by 2025, portable and user-friendly urine collection systems are in high demand. Medical PVC films enable lightweight, discrete solutions for elderly and bedridden patients receiving care at home.

Rural Healthcare Initiatives

Government programs like Ayushman Bharat are expanding healthcare access to rural populations. Affordable, reliable medical disposables including urine bags made from quality PVC films are essential for primary health centers and community health facilities serving remote areas.

Emergency & Ambulance Services

India's expanding emergency medical services network requires durable, leak-proof urine collection systems for patient transportation. Medical PVC films provide the necessary strength and flexibility for these demanding applications.

Who we are

DAHAI
Jiangsu Dahai Plastics Co., Ltd. was founded in 1996, is a professional production of various types of PVC film and printing PVC film technology of private enterprises. We mainly produce super transparent film, ordinary transparent film, toy film, bath film, raincoat film, electrical tape film, cold film, non-stick film, decorative film, PEVA film, particles, tablecloth, shower curtain, urine bag.
The company has more than 20 production lines, more than 450 employees, of which 30% are technical management personnel, and has a sound management system. Covers an area of more than 120,000 square meters, annual output of more than 100,000 tons, annual sales of more than 1 billion. The company continues to introduce advanced production equipment and technology. The product quality reaches the international standard, the company's products not only sell well in the domestic market, but also exported to South America, Southeast Asia, Africa and other places.
DAHAI Plastics Company

Why Choose DAHAI for Medical PVC Films in India?

With over 27 years of manufacturing excellence, DAHAI brings unparalleled expertise to the Indian medical plastics market. Our medical-grade PVC urine bag films are manufactured using state-of-the-art technology in CNAS-accredited laboratories, ensuring compliance with international standards including ISO 13485, EN-71, ASTM-F-963, and RoHS.

Our commitment to the Indian market extends beyond product supply. We offer technical consultation, customized formulation development, and responsive customer support to help Indian medical device manufacturers and healthcare providers meet their specific requirements. Our established export network to Southeast Asia positions us perfectly to serve the growing Indian healthcare sector with reliability and consistency.

Our Track Record

DAHAI
The total registered capital of several projects under the company group is 40 million dollar, total assets reach 140 million dollar, floor area is more than 120000sqm, with 20 imported environmental protection production lines, with an annual production capacity of 150,000 tons. In year 2018, we achieved sales of 180 million dollar, of which exports earned 10 million US dollars. The products are sold to more than 400 cities in 12 provinces and regions across the country, the market share ranks first among private enterprises in the province, and the products are exported to more than 10 countries and regions.
20
20 eco-friendly production lines
150,000
150,000 tons annual capacity
120,000+
120,000+ sqm operational footprint
$40M
$40M registered capital

Our World-Class Facilities

DAHAI Facility
DAHAI Production
DAHAI Laboratory
DAHAI Quality Control
DAHAI Manufacturing

Experience DAHAI Manufacturing Excellence

Our Quality

DAHAI

We possess laboratories accredited by China National Commission for Conformity Assessment (CNAS), which are equipped with many kinds of world advanced experimental equipment and physical and chemical testing-analysis instruments. In every experiment, in every test, even the slightest difference can be detected by our machines, which greatly guarantees the quality of our products.

DAHAI continues to invest resources, and we will work with university teams to develop products. Our technical department is constantly learning new technologies and combining them with our own situation, through which our ability to innovate is keeping improving.

We import all kinds of testing machines, such as universal testing machines, Agilent GC analyzers, gloss meters and cold-tolerance testing machines. Besides, we establish good cooperation with professional testing companies to meet customer's requirements. All of our products can meet the requirements of EN-71, ASTM-F-963, Model Toxics in Packaging Legislation (CONEG) and RoHS.

Contact us

Our Certifications

DAHAI
Certificate
Certificate
Certificate
Certificate
Certificate
Certificate

CORPORATE CULTURE

DAHAI
Company Mission

Make green materials, create a good and healthy life!

Company Vision

To become the domestic polymer material application industry leader, to build a world-class brand!

Enterprise Spirit

Independent innovation intelligent future! Team style: people-oriented safety first!

Business Philosophy

Integrity, pragmatic, efficient, win-win!

ENTERPRISE HISTORY

DAHAI
July 1996
Tongzhou Huaming Plastic Co., Ltd. was established.
December 2009
Tongzhou Huaming Plastics Co., Ltd. was changed to Jiangsu Dahai Plastics Co., LTD.
July 2010
Nantong Runyang Plastic Co., Ltd. was established.
December 2012
Dahai Real Estate Development Co., Ltd. was established.
April 2013
Field E-commerce company is established.
Oct 2013
Jiangyin Zhonglian Real Estate company was established.
In November 2014
Jiangyin Huayue Real Estate Development Co., Ltd. was established.
January 30, 2019
Jiangsu Houbang Industrial Co., LTD.

Dahai Innovation Journey

Complete realization from concept to market. Dahai Plastic assists customers around the world in developing and manufacturing products for packaging, medical supplies, building materials, toy supplies etc.

Plastic Bags Application Inflatable Toys Application Construction Industry Application Medical Industry Application
DAHAI Company DAHAI Facility DAHAI Production DAHAI Team DAHAI Quality

OEM Process for Indian Partners

Seamless Collaboration from Concept to Delivery

Confirm Needs

Our dedicated sales and technical teams engage closely with customers to gather detailed specifications, discuss project goals, and identify any unique challenges specific to the Indian market requirements.

Product Proofing

Once the needs are confirmed, we move into the product proofing phase. During this stage, we create prototypes or samples based on the agreed-upon specifications, ensuring compliance with Indian medical device standards.

Confirmed Sample

After thorough evaluation and refinement, we finalize the sample that both parties agree upon. The confirmed sample serves as the benchmark for all subsequent production runs.

Make-to-order

Our make-to-order approach allows us to tailor our production processes to meet individual client needs. Leveraging our flexible manufacturing capabilities, we ensure timely delivery to Indian partners.

Finished Inspection

Upon completion of production, each item undergoes a comprehensive finished inspection. Our quality assurance team employs advanced testing methods to verify compliance with international standards.

Cooperation

We actively seek feedback to continuously improve our services and adapt to evolving market demands. Through ongoing partnerships, we aim to be more than just a supplier to the Indian healthcare industry.